CUSIP: 68230A106
Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,233,813
-
Share change
-
-1,322,227
-
Total reported value
-
$2,114,000
-
Price per share
-
$0.50
-
Number of holders
-
27
-
Value change
-
-$665,453
-
Number of buys
-
10
-
Number of sells
-
10
Institutional Holders of ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) as of Q4 2016
As of 31 Dec 2016,
ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,233,813 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, PANAGORA ASSET MANAGEMENT INC, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Fund Advisors, SUSQUEHANNA INTERNATIONAL GROUP, LLP, KCG HOLDINGS, INC., NORTHERN TRUST CORP, and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.